The benefits of bisphosphonates in fracture reduction still far outweigh risks for atypical femur fractures (AFFs), but the study shows a higher risk for AFF with longer-term use and among Asian women.
Medscape Medical News
…read more
The benefits of bisphosphonates in fracture reduction still far outweigh risks for atypical femur fractures (AFFs), but the study shows a higher risk for AFF with longer-term use and among Asian women.
Medscape Medical News
…read more